SPDR S&P Biotech ETF (XBI) -1.5%
Biotech stocks are settling following Monday's rally. As a result, ETFs including XBI and the First Trust Amex Biotechnology Index Fund (FBT) are witnessing losses.
Dendreon (DNDN), the closely watched name that saw staggering gains at the start of the week, is giving back some of its winnings, dipping 2.6%.
All prices as of 2:13 PM ESTWritten by Don Dion in Williamstown, Mass.